All In Biotech

Free tool

FAERS Monitor: Abraxane

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021660 or its brand name (Abraxane, Paclitaxel). Reports on generic versions are filed under their own applications.

Reports

101,114

Serious

97,345

96% of reports

Hospitalization

41,399

Death reported

16,524

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea5,613
  • neutropenia5,563
  • off label use5,388
  • diarrhoea5,265
  • dyspnoea5,190
  • anaemia4,891
  • death4,509
  • malignant neoplasm progression4,508
  • fatigue4,309
  • neuropathy peripheral4,095
  • pyrexia3,984
  • disease progression3,938
  • vomiting3,898
  • myelosuppression3,829
  • febrile neutropenia3,772

Reports by year received

View as table
YearReports
2004626
2005853
2006665
2007687
2008946
20091,096
20101,148
20111,956
20122,607
20132,742
20142,623
20153,931
20164,464
20174,527
20186,481
20196,495
20206,372
20216,872
20228,471
20238,823
202410,274
202510,694
20267,760

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,953,045 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
myelosuppressionSignal3,82924.623.877,672
febrile neutropeniaSignal3,77212.512.137,680
malignant neoplasm progressionSignal4,5089.59.333,065
neuropathy peripheralSignal4,0959.39.029,200
neutropeniaSignal5,5638.88.637,284
disease progressionSignal3,9387.16.920,159
anaemiaSignal4,8915.45.317,462
pyrexiaSignal3,9842.42.33,306
dyspnoea5,1901.91.92,311
vomiting3,8981.71.71,219
diarrhoea5,2651.71.71,560
nausea5,6131.51.4897
off label use5,3881.31.2346
fatigue4,3091.21.189
death4,5091.11.134

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.